This Study illustrates that LINC00689 promotes prostate cancer progression through activation of the Wnt pathway via the miR-496/CTN-NB1 axis, and thus, studying LINC0068 may provide a new direction for further treatment of prostate cancer. This evidence concerns the gene CD177 and prostate carcinoma.